CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 24  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0641
LYS 10.0526
GLU 20.0488
LEU 30.0382
ARG 40.0316
CYS 50.0201
GLN 60.0192
CYS 70.0076
ILE 80.0185
LYS 90.0153
THR 100.0115
TYR 110.0138
SER 120.0120
LYS 130.0074
PRO 140.0060
PHE 150.0069
HIS 160.0164
PRO 170.0197
LYS 180.0231
PHE 190.0144
ILE 200.0133
LYS 210.0184
GLU 220.0144
LEU 230.0053
ARG 240.0081
VAL 250.0100
ILE 260.0200
GLU 270.0374
SER 280.0376
GLY 290.0485
PRO 300.0625
HIS 310.0279
CYS 320.0261
ALA 330.0371
ASN 340.0258
THR 350.0200
GLU 360.0134
ILE 370.0059
ILE 380.0045
VAL 390.0084
LYS 400.0098
LEU 410.0066
SER 420.0161
ASP 430.0162
GLY 440.0054
ARG 450.0104
GLU 460.0105
LEU 470.0109
CYS 480.0090
LEU 490.0115
ASP 500.0136
PRO 510.0098
LYS 520.0091
GLU 530.0216
ASN 540.0255
TRP 550.0146
VAL 560.0134
GLN 570.0167
ARG 580.0232
VAL 590.0182
VAL 600.0132
GLU 610.0223
LYS 620.0229
PHE 630.0177
LEU 640.0120
LYS 650.0031
ARG 660.0126
ALA 670.0134
GLU 680.0263
ASN 690.0641

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.